Roche Holding
- All
- News
-
Opinion | Sunak To Biden, No Incumbent Has It Easy This Year - Thanks To Economy
From South Korea and Turkey to the UK and the US, incumbent heads of state in most poll-bound countries are struggling to hold on to power and popularity.
-
Hetero Gets Emergency Use Nod For Generic Version Of Covid Drug Tocilizumab
Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
-
High Court Asks Centre To Meet Pharma Firm For Immediate Supply Of Tocilizumab Drug
In view of the "acute shortage" of Tocilizumab drug, which is prescribed to a large number of Covid patients, the high court has directed the Centre and Department of Pharmaceuticals to hold a meeting with Roche, which sells the drug.
-
China Approves Roche Arthritis Drug To Treat Some Coronavirus Patients
China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment regimens to help the infected recover.
-
Single-Dose Flu Pill Wins FDA Approval Ahead Of Winter Season
The drug, which is to be marketed globally by Shionogi & Co. and Roche Holding, gained Food and Drug Administration approval just as the winter flu season begins.
-
Study Finds Targeted Cancer Drugs May Work In Range Of Tumor Types
Early results from a clinical trial of Roche Holding AG cancer drugs released on Saturday suggest some promise in matching treatments based on abnormalities found in a patient's tumor rather than the organ in which the cancer was originally detected.
-
Opinion | Sunak To Biden, No Incumbent Has It Easy This Year - Thanks To Economy
From South Korea and Turkey to the UK and the US, incumbent heads of state in most poll-bound countries are struggling to hold on to power and popularity.
-
Hetero Gets Emergency Use Nod For Generic Version Of Covid Drug Tocilizumab
Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
-
High Court Asks Centre To Meet Pharma Firm For Immediate Supply Of Tocilizumab Drug
In view of the "acute shortage" of Tocilizumab drug, which is prescribed to a large number of Covid patients, the high court has directed the Centre and Department of Pharmaceuticals to hold a meeting with Roche, which sells the drug.
-
China Approves Roche Arthritis Drug To Treat Some Coronavirus Patients
China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment regimens to help the infected recover.
-
Single-Dose Flu Pill Wins FDA Approval Ahead Of Winter Season
The drug, which is to be marketed globally by Shionogi & Co. and Roche Holding, gained Food and Drug Administration approval just as the winter flu season begins.
-
Study Finds Targeted Cancer Drugs May Work In Range Of Tumor Types
Early results from a clinical trial of Roche Holding AG cancer drugs released on Saturday suggest some promise in matching treatments based on abnormalities found in a patient's tumor rather than the organ in which the cancer was originally detected.
